MSD
A collaborative research-focused postdoctoral role in neurodegenerative disease, developing AI/ML methods for biomarker discovery, patient stratification, and disease modeling within a biopharmaceutical company.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
31% above the average for this role
MSD ends takeover talks with Revolution Medicines
1 month ago
Sr. Scientist, Neuroscience Computational Biology
Takeda Pharmaceutical Company Limited
Principal Scientist, Translational Neuroscience
Bexorg
Postdoctoral Fellow - Computational Biology & Spatial Multi-Omics
EMBL
Manager, Clinical Biomarker Assays, Translational Science - Neuroscience
Arvinas
Post Doctoral Fellow
Saint Louis University
Head of Quantitative Biomarker Sciences (all genders)
Evotec